Comment on: Evaluation of cefazolin antimicrobial prophylaxis during cardiac surgery with cardiopulmonary bypass

J Antimicrob Chemother. 2018 Sep 1;73(9):2587-2588. doi: 10.1093/jac/dky228.

Authors

Martin Andreas¹, Markus Zeitlinger², Doris Hutschala³

Affiliations

¹ Division of Cardiac Surgery, Department of Surgery, Medical University of Vienna, Vienna, Austria.
² Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
³ Division of Cardiothoracic and Vascular Anaesthesia & Critical Care Medicine, Department of Anaesthesia, General Intensive Care and Pain Management, Medical University of Vienna, Vienna, Austria.

PMID: 29945205
DOI: 10.1093/jac/dky228

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Bacterial Agents
Anti-Infective Agents*
Antibiotic Prophylaxis
Cardiac Surgical Procedures*
Cardiopulmonary Bypass
Cefazolin

Substances

Anti-Bacterial Agents
Anti-Infective Agents
Cefazolin